Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60